Conference Day 2: Pharma Supply Chain Strategies and Challenges

08.00 Registration and LogiPharma Breakfast Round-tables Registration and LogiPharma Breakfast Round-tables

08.50 Chairperson's welcome and opening remarks Chairperson's welcome and opening remarks

09.00 Keynote opening address: The push into the emerging markets – what this means for the supply chain Helle Skov, Vice President, Global Supply Chain, Takeda Lack of growth in developed markets – what are the next steps for life science companies? The shift in focus to the bottom line, given lacking top line profits Maintaining quality under pressure Getting smarter on distribution strategy and channels Assessing changing customer behaviours and the shift in demographics Mastering complexity and knowing the trust cost to serve Helle Skov Vice President, Global Supply Chain, Takeda Helle Skov is a member of Global Operations Leadership team in Takeda and is head of Global Supply Chain, a transnational organization, which includes Supply Chain Coordination, Supply Chain Development, Distribution and Warehousing, Direct Procurement, External Supply and Product Evaluation, Launch and LCM. She joined Nycomed in 2006 and has held different position within Business Support, Manufa [read more]

09.30 Strategy: Visibility – The foundation for E2E supply chain performance and resilience Andy Robson, Director, Infosys Lodestone Increasing complexity of the pharma supply chain and the evolving regulatory landscape Balancing performance, complexity and risk across functional and corporate boundaries – a core supply chain competence, built on accurate and sustainable visibility of the chain Achieving performance and resilience –exploiting E2E supply chain visibility and collaborative processes to radically improve your decision making and execution capabilities Andy Robson Director, Infosys Lodestone Andy is a Director at Infosys Lodestone in UK with 15 years of supply chain consulting experience in a range of industries but especially Life Sciences and CPG. He started his career in industry working at ICI for 9 years in Sales & Marketing roles, moving to Supply Chain Planning and Operational Excellence before becoming a management consultant. In consulting Andy has worked for [read more]

10.00 Outside industry innovation: A smarter supply chain by learning from the Automotive industry – Viable opportunities or wishful thinking? Piero Sciotto, Senior Director, Head of Product Supply, Daiichi-Sankyo Europe Linking theory and personal experiences of a former automotive professional Pharmaceuticals vs. Automotive: Comparison of the status quo Supply Chain Challenges & Cultural change Key findings related to Supply Chain cost and operations Globalization: Opportunities and Threats Cost containment in times of change Risk management: Area of conflict or opportunity? Supply chain visibility: Reporting and Performance Management Communication & Integration: From the connection with suppliers to the connection with customers Piero Sciotto Senior Director, Head of Product Supply, Daiichi-Sankyo Europe Piero Sciotto is Senior Director and Head of Product Supply at Daiichi Sankyo Europe GmbH in Munich/Germany, a pharmaceutical company. He is in charge of topics like demand planning, supply & production planning, the S&OP process, pan European inventory levels, the management of contract manufacturers, procurement of direct material, the 3rd party distribution n [read more]

Morning refreshments and networkingSpeaker’s Corner 10.30 Morning refreshments and networking Morning refreshments and networking Morning refreshments and networking 10.30 Speaker’s Corner Speaker’s Corner During the break, visit an area of the event dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly and candidly about any questions not covered during their session.

11.00 Breakthrough technology that drives operational and competitive advantage for healthcare companies Edgar Van Der Linden, Regional Commercial Director, Alloga Europe Tim Gittins, IT Director, Alloga Europe Technology solutions that drive tangible value for healthcare companies Enabling better and faster implementation Greater information and insight into operational performance Edgar Van Der Linden Regional Commercial Director, Alloga Europe Edgar van der Linder is the European Sales Director at Alloga, based in Weybridge, UK. He has been with the company for two years and is responsible for business development across Europe, working closely with both international clients and all of Alloga’s country organisations and partners. He focuses on European and regional solutions for pharmaceutical clients. Prior to joining Alloga, Edgar wa [read more] Tim Gittins IT Director, Alloga Europe Tim Gittins is the IT Director for Alloga Europe and is responsible for the development and delivery of the groups IT Strategy and has worked in the area of Pharmaceutical Pre Wholesale for nearly ten years. Mr Gittins held the position of IT Director at UniDrug Distribution group before moving to Alloga to head up their European IT. Tim holds a Honours Degree in Computing Science from Nottingham [read more]

11:30 Case study: Toward a mature Supply Chain process sustainability model – Global demand planning implementation project Antioco Cerina, Global Supply Chain Director, Process Stewardship, Bristol-Myers Squibb Positioning processes as valuable cornerstones and assets to the global supply chain Improving and aligning a disjointed global demand planning process The key supply chain impacts and capabilities Assuring process sustainability post-change management Critical pitfalls and project success factors Antioco Cerina Global Supply Chain Director, Process Stewardship, Bristol-Myers Squibb Antioco Cerina is currently the Supply Chain Global Production Planning Process Stewardship Director for Bristol-Myers Squibb. He holds a bachelor degree in Mathematics and Information System and started his career in the Information System area where he acquired a solid experience in complex systems and processes implementation techniques. He has been working for the last 24 years in different co [read more]

12.00 Outside industry innovation: Pharma versus FMCG: What can Pharma supply chain performance can learn from end-to-end complexity management in Fast Moving Consumer Goods? Oliver Scheel, Partner, A.T. Kearney Overview of benchmarks comparing Pharma vs. FMCG operations and supply chain performance Importance of end-to-end data transparency of the full value chain as a pre-requisite to improve the supply chain and distribution networks Why a different mind-set is required. Data analysis and smart concepts are not enough. Transforming organizational culture of the organization and coaching leaders during the transition What specifically can Pharma learn from FMCG to improve current performance at reduced costs? Oliver Scheel Partner, A.T. Kearney Dr. Oliver Scheel has been with A.T. Kearney since 2000. With 18 years of combined consulting and industry experience, he is a leader in A.T. Kearney’s Health Practice in D/A/CH. He is also responsible for End-to-End Complexity Management team across industries as part of the EMEA Operations Practice. He has multi-year experience in strategic operations consulting with a focus on designing integra [read more]

Networking LunchSpeaker’s Corner 12.30 Networking Lunch Networking Lunch Networking Lunch 12.30 Speaker’s Corner Speaker’s Corner During the break, visit an area of the event dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly and candidly about any questions not covered during their session.

13.30 Exhibition Prize Drawing - In the Main Conference Room Exhibition Prize Drawing

13.45 Case study: Going beyond Europe – Distribution strategies into Israel and emergent European markets Aviad Bussi, Managing Director, SLE, Teva group Market introduction – Israel unique pharmaceutical distribution market structure & specifics Evolution in our logistics during the last decade from a view of logistic centers' projects: Innovation in processes & automation Cutting-edge QA standard & compliance Unique services & customers What does the future have in store for pharma distribution? Logistics platform as a leverage for adding value to customers and creating integrated distribution chain advantages Making a difference to the patient's life, focus on the patient – future trends Aviad Bussi Managing Director, SLE, Teva group Aviad has been with Teva since 2002. He held various positions as Commercial Operations Director in EU and Israel. Within these roles, he designed and implemented transformation of end-to-end supply chains as well as managing the on-going operation. He is focused on achieving quick results whilst building infrastructure of processes, systems and resources, in order to create value and identify pot [read more]

14.15 Case study: Cross-functional teamwork to improve the product launch and product change processes Oliver Glemser, Director Global Supply Chain Development, Ferring The challenge of speaking the same language across the functions Guidelines to achieve shorter lead times on Product Launches Recognizing a need for a Product Lifecycle Management solution The starting point: a Product Catalogue of launchable products and a simple Launch Planning & Tracking Movement towards a sustainable Product Lifecycle Management solution - recommendations on how to get it started Initial results and problems to overcome Oliver Glemser Director Global Supply Chain Development, Ferring Oliver Glemser holds the position of Director Global Supply Chain Development at Ferring Pharmaceuticals in Saint-Prex, Switzerland. He has worked close to 20 years in Supply Chain, Procurement and Logistics roles. At Ferring, he was leading implementation projects such as Sales & Operations Planning, Supply Chain Performance Management, Advanced Planning System, Distribution Effic [read more]

14.45 The revised 2013 GDP guidelines A to Z Yoram Eshel, Senior Director, Global Shipping and Logistics, Teva Monika Derecque-Pois, Managing Director, GIRP What has changed and what this means for you right now Route qualification Packaging considerations Where it’s out of your hands – becoming a people programme to ensure duty of care Execution of quality management – how to manage the complexity Risk-based assessments Impact of quality standards and SOPs on the process on agility and compliance What ownership should logisticians have checked off Impact on distributors and the vendor landscape – will we see firms exiting the pharma space? Yoram Eshel Senior Director, Global Shipping and Logistics, Teva Yoram has an MBA in Economics and Business Administration. He has vast experience in global transportation systems and processes including all modes of transportation, Forwarding, Customs compliance programs, GDP and temperature management, Security, Safety and Environment implications. Yoram has specialized in the Pharma and API industries including clinical trials, medical devices and bio pharma [read more] Monika Derecque-Pois Managing Director, GIRP Monika Derecque-Pois is the Director General of the European Association of Pharmaceutical Full-line Wholesalers (known by its French acronym, GIRP). GIRP is headquartered in Brussels and brings together over 750 pharmaceutical full-line wholesaling companies and their national associations from 31 countries. Monika was appointed to her current position in 2001, having previously served as Europea [read more]

Afternoon coffee and networkingSpeaker’s Corner 15.15 Afternoon coffee and networking Afternoon coffee and networking Afternoon coffee and networking 15.15 Speaker’s Corner Speaker’s Corner During the break, visit an area of the event dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly and candidly about any questions not covered during their session.

15.50 LogiPharma Café Session Speakers from the earlier sessions will host themed round-table discussions and brainstorming sessions. This session allows you to go in depth into the topic and ask questions not covered in their presentation. Andy Robson, Director, Infosys Lodestone Piero Sciotto, Senior Director, Head of Product Supply, Daiichi-Sankyo Europe  Edgar Van Der Linden, Regional Commercial Director, Alloga Europe  Antioco Cerina, Global Supply Chain Director, Process Stewardship, Bristol-Myers Squibb  Oliver Glemser, Director Global Supply Chain Development, Ferring Pharmaceuticals

Chairperson's closing remarks & evening drinks reception – Hosted by A.T. Kearney No session description available.